🌱 KidneyEnergy.com

← brief for 2026-09-11 · Slowing decline

Effects of GLP-1 receptor agonists on the incidence of contrast-induced acute kidney injury in patients with Type 2 diabetes mellitus undergoing coronary interventions.

Article C Peer reviewed Observational

Key takeaways

This observational study found that type 2 diabetes patients who took GLP-1 drugs before heart procedures had less sudden kidney injury after contrast dye was used, but because it is not a randomized trial, it shows only a link—not proof the drug caused the benefit.

Who did this work

Oksen D · Aslan M · Yavuz YE · Kaynak C · Serin E

Source

Article · PubMed, the drug frontier · 2026 Aug 27
https://pubmed.ncbi.nlm.nih.gov/42723898/